PRELUDE CAPITAL MANAGEMENT, LLC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is 67076P102. A total of 31 filers reported holding NYMOX PHARMACEUTICAL CORP in Q2 2014. The put-call ratio across all filers is 5.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2014$45,0008,9600.01%
Other shareholders

There were no reported owners of NYMOX PHARMACEUTICAL CORP in Q2 2014.

NameSharesValueWeighting ↓
View complete list of NYMOX PHARMACEUTICAL CORP shareholders